Methyl 2-(1,1-dioxoisothiazolidin-2-yl)-4-(2-oxooxazolidin-3-yl)benzoate → 3-{3-(1,1-Dioxoisothiazolidin-2-yl)-4-[4-(3,5,6-trimethylpyridin-2-yl)piperazine-1-carbonyl]phenyl}oxazolidin-2-one
Reaction equation
[O:1]=[S:2]1(=[O:23])[CH2:6][CH2:5][CH2:4][N:3]1[C:7]1[CH:16]=[C:15]([N:17]2[CH2:21][CH2:20][O:19][C:18]2=[O:22])[CH:14]=[CH:13][C:8]=1[C:9]([O:11]C)=O.[CH3:24][C:25]1[C:26]([N:33]2[CH2:38][CH2:37][NH:36][CH2:35][CH2:34]2)=[N:27][C:28]([CH3:32])=[C:29]([CH3:31])[CH:30]=1>>[O:23]=[S:2]1(=[O:1])[CH2:6][CH2:5][CH2:4][N:3]1[C:7]1[CH:16]=[C:15]([N:17]2[CH2:21][CH2:20][O:19][C:18]2=[O:22])[CH:14]=[CH:13][C:8]=1[C:9]([N:36]1[CH2:37][CH2:38][N:33]([C:26]2[C:25]([CH3:24])=[CH:30][C:29]([CH3:31])=[C:28]([CH3:32])[N:27]=2)[CH2:34][CH2:35]1)=[O:11]Participants
3
Procedure
By reaction and treatment in the same manner as in Example 63 and using methyl 2-(1,1-dioxoisothiazolidin-2-yl)-4-(2-oxooxazolidin-3-yl)benzoate (170 mg) described in Preparation Example 117 and 1-(3,5,6-trimethylpyridin-2-yl)piperazine (103 mg) described in Preparation Example 175, the title compound (64.2 mg) was obtained.
Workup
- customBy reaction and treatment in the same manner as in Example 63
- customdescribed in Preparation Example 175
Sources & evidence
- ORD record
- ord-b15ee2d5de514b0eb0591d782bda9e52
- Source dataset
- uspto-grants-2013_01
- Patent number
- US08354401B2
Reaction notes
Loading…